Found vs ArkeaBio

Side-by-side comparison of AI visibility scores, market position, and capabilities

Found

EmergingFinancial Technology

Self-Employed Banking

Found is a banking and tax platform built for self-employed workers, combining a business account with automated tax tracking, estimated payments, and bookkeeping.

About

Found is a fintech company founded in 2019 that provides an all-in-one banking and tax solution specifically designed for the self-employed, including freelancers, contractors, gig workers, and solo business owners. The platform combines a business checking account and debit card with automated bookkeeping, real-time tax liability tracking, and automatic quarterly estimated tax payments, addressing the administrative burden that disproportionately affects independent workers who manage their own finances without a finance department. Found raised $60M in Series B funding and serves hundreds of thousands of self-employed customers across industries including creative services, consulting, construction, and gig platforms. The company differentiates from general business banking by deeply integrating tax management, helping users understand their tax exposure in real time and set aside appropriate funds automatically. As the independent workforce continues to grow as a share of the economy, Found addresses an underserved segment that traditional banks have historically ignored in favor of W-2 employed consumers.

Full profile

ArkeaBio

EmergingAgTech

Livestock Biotech (Methane Reduction)

$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.

About

ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.